Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of myelogenous leukemia: current status and investigational options.

× No keyword cloud information.

19 in total

1. A Study of Haemostatic Parameters in Patients of Chronic Myeloid Leukaemia.

Authors: Ankur Jain; Naresh Gupta; Tejinder Singh; Sunita Agarwal
Journal: J Clin Diagn Res Date: 2016-07-01

Review 2. Treatment of chronic myelogenous leukaemia.

Authors: B Simonsson
Journal: Med Oncol Date: 1998-04 Impact factor: 3.064

3. Dose selection and population pharmacokinetics of PEG-Intron in patients with chronic myelogenous leukaemia.

Authors: Samir Gupta; Juif Jen; Karen Kolz; David Cutler
Journal: Br J Clin Pharmacol Date: 2006-08-30 Impact factor: 4.335

Review 4. Bcl-2 antagonists: a proof of concept for CLL therapy.

Authors: Kumudha Balakrishnan; Varsha Gandhi
Journal: Invest New Drugs Date: 2013-08-02 Impact factor: 3.850

5. Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factor.

Authors: Jorge Cortes; Alfonso Quintás-Cardama; Dan Jones; Farhad Ravandi; Guillermo Garcia-Manero; Srdan Verstovsek; Charles Koller; Jody Hiteshew; Jenny Shan; Susan O'Brien; Hagop Kantarjian
Journal: Cancer Date: 2010-09-30 Impact factor: 6.860

Review 6. Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Authors: Christian Sillaber; Matthias Mayerhofer; Hermine Agis; Verena Sagaster; Christine Mannhalter; Wolfgang R Sperr; Klaus Geissler; Peter Valent
Journal: Wien Klin Wochenschr Date: 2003-08-14 Impact factor: 1.704

Review 7. Oral chemotherapy agents in the treatment of leukaemia.

Authors: R B Geller; S P Dix
Journal: Drugs Date: 1999 Impact factor: 9.546

8. Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML).

Authors: Joshua F Zeidner; Douglas E Gladstone; Marianna Zahurak; William H Matsui; Christopher Gocke; Richard J Jones; B Douglas Smith
Journal: Leuk Res Date: 2014-05-29 Impact factor: 3.156

9. Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.

Authors: Andrea V Leisewitz; Eric I Zimmerman; Shannon Z Jones; Jing Yang; Lee M Graves
Journal: Nucleosides Nucleotides Nucleic Acids Date: 2008-06 Impact factor: 1.381

10. Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2.

Authors: Ana L Romero-Weaver; Hsiang-Wen Wang; Håkan C Steen; Anthony J Scarzello; Veronica L Hall; Faruk Sheikh; Raymond P Donnelly; Ana M Gamero
Journal: Mol Cancer Res Date: 2010-01-12 Impact factor: 5.852